The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tepotinib + osimertinib for EGFR mutant (EGFRm) NSCLC with MET amplification (METamp) after first-line (1L) osimertinib.
 
Daniel Shao-Weng Tan
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; C4 Therapeutics; Loxo; Merck; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Tae Min Kim
Consulting or Advisory Role - AstraZeneca/MedImmune; Janssen Oncology; Novartis; Regeneron; Samsung Bioepis; Takeda; Yuhan
Speakers' Bureau - IMBdx; Janssen Research & Development; Takeda
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Boryung; Novartis; Roche/Genentech
 
Valentina Guarneri
Consulting or Advisory Role - Eisai; Exact Sciences; Gilead Sciences; Lilly; Merck Serono; MSD; Novartis; Olema Oncology
Speakers' Bureau - Amgen; AstraZeneca; GlaxoSmithKline; Lilly; Novartis
Research Funding - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Roche (Inst); Synthon (Inst)
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Gilead/Forty Seven
 
PEI JYE VOON
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Janssen-Cilag (Inst); Johnson & Johnson (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); ROCHE (Inst); Viracta Therapeutics (Inst)
 
Boon Khaw Lim
No Relationships to Disclose
 
Marie Wislez
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen; Merck KGaA; MSD; Novartis; Pfizer; Roche
 
Cheng Huang
No Relationships to Disclose
 
Chong Kin Liam
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly O.; MSD; Novartis; Pfizer; Roche; Zuellig Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly O.; MSD; Novartis; Pfizer; Roche; Zuellig Pharma
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Julien Mazieres
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Merck KGaA; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
 
Lye Mun Tho
Honoraria - AstraZeneca; Boehringer Ingelheim; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Novartis; Pfizer; Roche
 
Hidetoshi Hayashi
Honoraria - Amgen; AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Guardant Health; Lilly; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Janssen
Research Funding - Abbvie (Inst); AC Medical (Inst); Astellas Pharma (Inst); AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); EPS Associates Co., Ltd. (Inst); GlaxoSmithKline (Inst); Japan Clinical Research Operations (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); Novartis (Inst); Ono Pharmaceutical; Otsuka (Inst); PAREXEL (Inst); Pfizer (Inst); PPD-SNBL (Inst); Quintiles Inc. (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
Patents, Royalties, Other Intellectual Property - Sysmex
 
Nguyen Nhung
No Relationships to Disclose
 
Puey Ling Chia
Honoraria - AstraZeneca; Lung Cancer Consortium Singapore
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; MSD; Pfizer
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - IASLC
 
Filippo de Marinis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
 
Xiuning Le
Consulting or Advisory Role - Abbvie; ArriVent Biopharma; AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Lilly; EMD Serono; Hengrui Therapeutics; Janssen Oncology; Lilly; Novartis; Sensei Biotherapeutics; Spectrum Pharmaceuticals
Research Funding - ArriVent Biopharma (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Regeneron (Inst); Teligene (Inst)
Travel, Accommodations, Expenses - EMD Serono; Spectrum Pharmaceuticals
 
Niki Karachaliou
Employment - Merck KGaA
 
Sabine Brutlach
Employment - Merck KGaA
 
Svenja Adrian
Employment - Merck KGaA
 
Barbara Ellers-Lenz
Employment - Merck KGaA
 
Yi-Long Wu
Honoraria - AstraZeneca; BeiGene Beijing; Boehringer Ingelheim; Bristol-Myers Squibb/China; Hengrui Pharmaceutical; Lilly; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
Research Funding - BMS (Inst); Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)